mankind pharma semaglutide

Drug compounders sue FDA over semaglutide status

Compounders sue FDA again over declaring end of shortage for Novo's semaglutide

Compounding pharmacies aren’t surrendering their ability to create cheaper knockoff versions of Eli Lilly and Novo Nordisk’s weight loss drugs without a fight. | Compounding pharmacies aren’t surrendering their ability to create cheaper knockoff versions of Eli Lilly and Novo Nordisk’s weight loss drugs without a fight.

Seeking Alpha on MSN · 3d

Drug compounders sue FDA over semaglutide status: report

Makers of copycat versions of Novo Nordisk's (NVO) weight-loss drug semaglutide, also known as Ozempic and Wegovy, are suing the FDA for removing the drug from its shortage list.

Yahoo · 3d

Drug compounders sue FDA over declaration ending Wegovy shortage

Telehealth provider Hims & Hers said it will tell consumers they need to seek “alternative options on the commercial dosing,” but in earnings Monday still forecast higher revenue and profits in 2025.

Mankind Pharma sets sights on Novo Nordisk's anti-obesity drug Semaglutide

The firm is focusing on specialty chronic therapies like immunotherapy, antibody-drug conjugates, and gene therapy drugs, ...

Ozempic play: Mankind Pharma in the fray for weight-loss drugs

Besides Mankind, Natco Pharma, Dr Reddy’s, Sun Pharma and others are already gearing up for launches of weight-loss drugs ...

2don MSN

Mankind Pharma develops oral anti-obesity drug, eyes global breakthrough

If successful, Mankind’s drug would be the first oral small-molecule alternative, offering a pill-based treatment.

FiercePharma7d

Novo Nordisk's semaglutide shortage officially concludes in the US, spelling major threat for weight loss drug compounders

On Friday, the FDA reclassified the semaglutide shortage—which had covered multiple doses of Wegovy for obesity and Ozempic for type 2 diabetes—as "resolved" on its online drug shortage database.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results